Artificial intelligence has been a buzzphrase in healthcare for years, but one only needs to look as far as IBM Watson—sold off to private equity this year—to see that the early predictions of AI diagnosis, AI-designed treatment, AI patient monitoring and AI cost savings haven’t come to fruition.  

At least not yet. At this event, Fierce Healthcare will explore how far we have come in tapping AI’s potential to improve healthcare outcomes and operations alike—and how far we still have to go.